tamsulosin has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alamin, MA; Alammari, RB; Alharbi, AO; Alonazi, AS; Alrasheed, NM; Alshammari, TK; Bin Dayel, AF | 1 |
| Hou, Y; Liu, N; Ren, H; Shang, W; Yin, Z; Zuo, S | 1 |
| Hu, W; Sun, C; Sun, L; Zhang, L; Zhou, S | 1 |
3 other study(ies) available for tamsulosin and Cirrhosis
| Article | Year |
|---|---|
α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.
Topics: Animals; Body Weight; Fibrosis; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Rats, Wistar; Signal Transduction; Tamsulosin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2023 |
Inhibition of α1-adrenoceptor reduces TGF-β1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Receptors, Adrenergic, alpha-1; Renal Insufficiency, Chronic; Smad3 Protein; Tamsulosin; Transforming Growth Factor beta; Urethral Obstruction | 2020 |
Tamsulosin attenuates high glucose- induced injury in glomerular endothelial cells.
Topics: Cytokines; Diabetic Nephropathies; Endothelial Cells; Fibrosis; Glucose; Humans; Inflammation; Kidney Glomerulus; Oxidative Stress; Tamsulosin | 2021 |